KMU is associated with eleven major research centers and networks, and is engaged in research partnerships with other universities, government and industry in Taiwan and other countries.
The MedicoGenomic Research Center of Kaohsiung Medical University has successfully developed colorectal cancer diagnostic chip and determined molecular markers for tumors (including DNA and RNA markers) which can be used in the laboratory or clinical tests.